Disease%20Progression
Showing 9976 - 10000 of >10,000
MSA Trial in Boston ([F-18]PBR06)
Completed
- MSA
-
Boston, MassachusettsMovement Disorders Clinic, 60 Fenwood Road
Apr 22, 2021
Identification of Novel Markers of Human Lung Disease
Recruiting
- Lung Diseases, Interstitial
- novel biomarkers of lung disease
-
Columbus, OhioDavis Heart and Lung Research Institute
Oct 27, 2021
Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))
Active, not recruiting
- Prostate Cancer
- ARN-509 (Phase 1)
- ARN-509 (Phase 2)
-
San Diego, California
- +14 more
Jan 17, 2023
Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)
Recruiting
- Advanced Hepatocellular Carcinoma
- Bifidobacterium Bifidum Oral Product
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-Sen University
Nov 16, 2022
Parkinson's Disease Trial in Ferrara (Deep Brain Stimulation)
Recruiting
- Parkinson's Disease
- Deep Brain Stimulation
-
Ferrara, Emilia Romagna, ItalyUniversity Hospital of Ferrara - Arcispedale Sant'Anna
Aug 27, 2021
Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic
Recruiting
- Liver and Intrahepatic Bile Duct Carcinoma
- +5 more
- Dexamethasone
- +6 more
-
Portland, OregonOHSU Knight Cancer Institute
Oct 11, 2022
Malignant Tumor, Nausea, Vomiting Trial in Houston (Netupitant, Palonosetron, Palonosetron Hydrochloride)
Completed
- Malignant Neoplasm
- +2 more
- Netupitant
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Mar 4, 2022
Luminal Metastatic breAst caNcer in Real-life Clinical pracTice
Completed
- HR+/HER2- Breast Cancer
- +2 more
-
Moscow, Russian FederationRussian Society of Clinical Oncology
Mar 29, 2023
Relapsed or Refractory Multiple Myeloma Trial in United States (CAR2 Anti-CD38 A2 CAR-T Cells)
Completed
- Relapsed or Refractory Multiple Myeloma
- CAR2 Anti-CD38 A2 CAR-T Cells
-
Jacksonville, Florida
- +3 more
Mar 14, 2022
Stem Cells in NF1 Tumors of the Central Nervous System
Suspended
- Neurofibromatosis Type 1
- Tumors of the Central Nervous System
- Collection of Stem Cells
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 8, 2022
Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
-
Portland, Oregon
- +1 more
Sep 23, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)
Terminated
- Squamous Cell Carcinoma of the Head and Neck
-
San Francisco, California
- +9 more
Dec 6, 2022
Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United
Completed
- Neurofibromatosis Type 1
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, California
- +11 more
Apr 22, 2022
Hypophosphatasia Trial in Durham
Recruiting
- Hypophosphatasia
-
Durham, North CarolinaDuke University Medical Center
Jan 27, 2022
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021
The Water Drinking Test in Glaucoma Study
Recruiting
- Glaucoma
- Modified Diurnal Tension Curve
-
London, United KingdomImperial College Ophthalmic Research Group
Mar 7, 2022
Early Diagnosis of Type 1 Diabetes
Recruiting
- Type 1 Diabetes
-
Orlando, FloridaAdventHealth Translational Research Institute
Feb 15, 2022
Metastatic Malignant Tumor in the Adult Brain, Primary Brain Tumor Trial in Duarte (procedure, drug, other)
Active, not recruiting
- Metastatic Malignant Neoplasm in the Adult Brain
- Primary Brain Tumor
- Therapeutic Conventional Surgery
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 16, 2022
Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)
Not yet recruiting
- Optic Pathway Glioma
- CHF6467
- Placebo
-
Rome, ItalyCatholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023
Esophageal Squamous Cell Carcinoma Trial in Tianjin (biological, drug, radiation)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Pembrolizumab
- +3 more
-
Tianjin, Tianjin, ChinaDepartment of minimally invasive esophageal surgery, Tianjin Med
May 26, 2022